Literature DB >> 26008807

The genetics of the epilepsies.

Christelle M El Achkar1, Heather E Olson, Annapurna Poduri, Phillip L Pearl.   

Abstract

While genetic causes of epilepsy have been hypothesized from the time of Hippocrates, the advent of new genetic technologies has played a tremendous role in elucidating a growing number of specific genetic causes for the epilepsies. This progress has contributed vastly to our recognition of the epilepsies as a diverse group of disorders, the genetic mechanisms of which are heterogeneous. Genotype-phenotype correlation, however, is not always clear. Nonetheless, the developments in genetic diagnosis raise the promise of a future of personalized medicine. Multiple genetic tests are now available, but there is no one test for all possible genetic mutations, and the balance between cost and benefit must be weighed. A genetic diagnosis, however, can provide valuable information regarding comorbidities, prognosis, and even treatment, as well as allow for genetic counseling. In this review, we will discuss the genetic mechanisms of the epilepsies as well as the specifics of particular genetic epilepsy syndromes. We will include an overview of the available genetic testing methods, the application of clinical knowledge into the selection of genetic testing, genotype-phenotype correlations of epileptic disorders, and therapeutic advances as well as a discussion of the importance of genetic counseling.

Entities:  

Mesh:

Year:  2015        PMID: 26008807     DOI: 10.1007/s11910-015-0559-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  165 in total

Review 1.  Epilepsy: new genes, new technologies, new insights.

Authors:  Byung In Lee; Kyoung Heo
Journal:  Lancet Neurol       Date:  2014-01       Impact factor: 44.182

2.  Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.

Authors:  Xiaochang Zhang; Jiqiang Ling; Giulia Barcia; Lili Jing; Jiang Wu; Brenda J Barry; Ganeshwaran H Mochida; R Sean Hill; Jill M Weimer; Quinn Stein; Annapurna Poduri; Jennifer N Partlow; Dorothée Ville; Olivier Dulac; Tim W Yu; Anh-Thu N Lam; Sarah Servattalab; Jacqueline Rodriguez; Nathalie Boddaert; Arnold Munnich; Laurence Colleaux; Leonard I Zon; Dieter Söll; Christopher A Walsh; Rima Nabbout
Journal:  Am J Hum Genet       Date:  2014-03-20       Impact factor: 11.025

3.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

4.  Epilepsy in Rett syndrome: association between phenotype and genotype, and implications for practice.

Authors:  Basil Cardoza; Angus Clarke; Jodie Wilcox; Frances Gibbon; Phil E M Smith; Hayley Archer; Anna Hryniewiecka-Jaworska; Mike Kerr
Journal:  Seizure       Date:  2011-07-20       Impact factor: 3.184

5.  Randomized trial of vigabatrin in patients with infantile spasms.

Authors:  R D Elterman; W D Shields; K A Mansfield; J Nakagawa
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

6.  Recurrent mutations in the CDKL5 gene: genotype-phenotype relationships.

Authors:  Nadia Bahi-Buisson; Nathalie Villeneuve; Emilie Caietta; Aurélia Jacquette; Helene Maurey; Gert Matthijs; Hilde Van Esch; Andrée Delahaye; Anne Moncla; Mathieu Milh; Flore Zufferey; Bertrand Diebold; Thierry Bienvenu
Journal:  Am J Med Genet A       Date:  2012-06-07       Impact factor: 2.802

7.  Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus.

Authors:  R Guerrini; F Moro; M Kato; A J Barkovich; T Shiihara; M A McShane; J Hurst; M Loi; J Tohyama; V Norci; K Hayasaka; U J Kang; S Das; W B Dobyns
Journal:  Neurology       Date:  2007-07-31       Impact factor: 9.910

Review 8.  Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?

Authors:  Ingrid E Scheffer; Yue-Hua Zhang; Floor E Jansen; Leanne Dibbens
Journal:  Brain Dev       Date:  2009-02-08       Impact factor: 1.961

9.  Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene.

Authors:  Fernando Díaz-Otero; Mar Quesada; José Morales-Corraliza; Carlos Martínez-Parra; Pilar Gómez-Garre; José M Serratosa
Journal:  Epilepsia       Date:  2007-09-26       Impact factor: 5.864

Review 10.  Genetic testing in the epilepsies-developments and dilemmas.

Authors:  Annapurna Poduri; Beth Rosen Sheidley; Sara Shostak; Ruth Ottman
Journal:  Nat Rev Neurol       Date:  2014-04-15       Impact factor: 42.937

View more
  14 in total

Review 1.  From Genetic Testing to Precision Medicine in Epilepsy.

Authors:  Pasquale Striano; Berge A Minassian
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

2.  The search for imaging biomarkers in psychiatric disorders.

Authors:  Anissa Abi-Dargham; Guillermo Horga
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

Review 3.  Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy.

Authors:  X Jiang; M Lachance; E Rossignol
Journal:  Prog Brain Res       Date:  2016-06-07       Impact factor: 2.453

4.  Attitudes Toward Epilepsy Genetics Testing Among Adult and Pediatric Epileptologists-Results of a Q-PULSE Survey.

Authors:  Lindsay Ferraro; John R Pollard; Ingo Helbig
Journal:  Epilepsy Curr       Date:  2016 Jan-Feb       Impact factor: 7.500

5.  GRIN and Bear the Diverse Functional Effects of Rare NMDA Receptor Variants.

Authors:  Matthew C Weston
Journal:  Epilepsy Curr       Date:  2017 Nov-Dec       Impact factor: 7.500

6.  When Should Genetic Testing Be Performed in Epilepsy Patients?

Authors:  Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2017 Jan-Feb       Impact factor: 7.500

Review 7.  Emerging roles of Na⁺/H⁺ exchangers in epilepsy and developmental brain disorders.

Authors:  Hanshu Zhao; Karen E Carney; Lindsay Falgoust; Jullie W Pan; Dandan Sun; Zhongling Zhang
Journal:  Prog Neurobiol       Date:  2016-03-08       Impact factor: 11.685

8.  Early diagnosis and experimental treatment with fenfluramine via the Investigational New Drug mechanism in a boy with Dravet syndrome and recurrent status epilepticus.

Authors:  Sara Trowbridge; Annapurna Poduri; Heather Olson
Journal:  Epileptic Disord       Date:  2021-12-01       Impact factor: 1.819

9.  A Novel Nonsense Mutation in Leucine-Rich, Glioma-Inactivated-1 Gene as the Underlying Cause of Familial Temporal Lobe Epilepsy.

Authors:  Sumaira Kanwal; Da Hye Yoo; Shahzad Tahir; Su Jung Lee; Min Hee Lee; Byung Ok Choi; Ki Wha Chung
Journal:  J Clin Neurol       Date:  2018-10       Impact factor: 3.077

Review 10.  Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

Authors:  Pavel Klein; Raymond Dingledine; Eleonora Aronica; Christophe Bernard; Ingmar Blümcke; Detlev Boison; Martin J Brodie; Amy R Brooks-Kayal; Jerome Engel; Patrick A Forcelli; Lawrence J Hirsch; Rafal M Kaminski; Henrik Klitgaard; Katja Kobow; Daniel H Lowenstein; Phillip L Pearl; Asla Pitkänen; Noora Puhakka; Michael A Rogawski; Dieter Schmidt; Matti Sillanpää; Robert S Sloviter; Christian Steinhäuser; Annamaria Vezzani; Matthew C Walker; Wolfgang Löscher
Journal:  Epilepsia       Date:  2017-12-15       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.